= Emerging. More than 5 years before clinical availability. (24.37%, 2023)
= Expected to be clinically available in 1 to 4 years. (39.50%, 2023)
= Clinically available now. (36.13%, 2023)
= In discovery stage of development. (0.00%, 2023)
= In process of being translated to clinical use. (0.00%, 2023)
= Clinically available now. (0.00%, 2023)
MSACL 2023 : Bhandari

MSACL 2023 Abstract

Self-Classified Topic Area(s): Various OTHER > Emerging Technologies

Poster Presentation
Poster #72b
Attended on Wednesday at 12:30

Urinary 2-Cyanoethylmercapturic Acid for Smoking Status Classification

Deepak Bhandari, Wanzhe Zhu, Ben Blount
Centers for Disease Control and Prevention, Atlanta, GA 30341

Deepak Bhandari, PhD (Presenter)
Centers for Disease Control and Prevention

Abstract

INTRODUCTION: Cotinine is a widely used biomarker for classifying cigarette smoking status; however, cotinine cannot differentiate use of combustible vs noncombustible tobacco products. Herein, we evaluated urinary 2-cyanoethylmercapturic acid (2CyEMA), a metabolite of acrylonitrile, as a complementary urinary biomarker for assessing smoke exposure.

OBJECTIVES: The primary objective of this study is to establish a reference cutoff value of urinary 2CyEMA for differentiating users of cigarettes from users of noncombustible tobacco product.
METHOD: We performed a receiver operating characteristic (ROC) curve analysis of a representative sampling of the adult U.S. population (NHANES 2011-2016, the special smoker subset, ages >20) for identifying optimal cutoff concentration by maximizing Youden’s J index. Smoking status was categorized based on the recent tobacco use questionnaire.

RESULTS: The cutoff concentration was 7.32 ng/ml with high sensitivity and specificity (≥0.925). When stratified by demo¬graphic variables, the cutoff concentrations varied among subgroups based on age, sex, and race/Hispanic origin. Non-Hispanic Blacks had the highest cutoff concentration (15.3 ng/ml), and Hispanics had the lowest (4.63 ng/ml). Females had higher cutoff concentrations (8.80 ng/ml) com¬pared to males (6.10 ng/ml). Among different age groups, the cutoff concentrations varied between 4.63 ng/ml (21–39 years old) and 10.6 ng/ml (for ≥60 years old). We also explored the creatinine adjusted cutoff values.

CONCLUSIONS: Urinary 2CyEMA is a selective smoke exposure biomarker that effectively distinguishes between people who use cigarettes from those using noncombustible tobacco products, including ecigarettes. Measuring urinary 2CyEMA in conjunction with cotinine can unequivocally assess tobacco smoke exposure.

Disclaimer: The views and opinions expressed in this report are those of the authors and do not necessarily represent the views, official policy or position of the U.S. Department of Health and Human Services or any of its affiliated institutions or agencies. The use of trade names is for identification purposes and does not imply endorsement by the Centers for Disease Control and Prevention, the Public Health Service, or the U.S. Department of Health and Human Services.


Financial Disclosure

DescriptionY/NSource
Grantsno
Salaryno
Board Memberno
Stockno
Expensesno
IP Royaltyno

Planning to mention or discuss specific products or technology of the company(ies) listed above:

no